Israeli stocks rose on Sunday, paced by Teva Pharmaceutical Industries Ltd., the world’s biggest maker of generic drugs, amid expectations it may get the right to sell copycat biotech drugs. The TA-25 Index gained 3.35, or 0.3 percent, to 1,122.45 in Tel Aviv, as 17 shares gained and eight declined. Investors bought and sold about NIS 1.3 billion in shares and convertibles on Sunday.
